Breeden Warns of Threat from High Rates as Splits on BOE Exposed
Bank of England Deputy Governor Sarah Breeden warned of the threat to the economy posed by leaving interest…
Buy GE Vernova T&D India at Rs 3170.10 | Upside: 5% – Market Trading Guide: Buy Coal India, multibagger GE Vernova and 2 smallcaps on Monday for up to 18% gains
India’s benchmark indices, the Nifty and Sensex, closed higher on Friday, marking their second straight day of gains…
Prologis, Amazon and Meta sign low-carbon concrete pact
Construction workers pouring wet concrete on a road. Jung Getty A version of this article first appeared in…
2 market-crash facts that surprised me 📉
📈The stock market rallied to all-time highs, with the S&P 500 setting an intraday high of 6,750.87 and…
Ford CEO Jim Farley hopes AI will help blue-collar workers, but ‘it’s hard to say that today’
AI has disrupted entry-level white-collar employment, but blue-collar workers are still looking for clues on how the tech…
More CEOs want Elon Musk–style ‘moonshot’ pay packages—but comp experts are raising alarms
The all-or-nothing moonshot pay plan was a gambit so risky even Axon Enterprise CEO Rick Smith’s wife was…
Market shows signs of a recovery as benchmarks end losing streak
India’s equity market is showing signs of a pullback after facing a brutal selling spree for eight straight…
Oregon job gains are greatest at the top of the wage scale
Oregon’s labor market has been anemic recently, with the manufacturing, construction and hospitality sectors all struggling. But growth…
CarMax’s “Wanna Drive” Campaign Focuses On Simplying Buying Used Cars
The “Wanna Drive” campaign introduces the CarMax House Band. CarMax CarMax, the largest retailer of used cars in…
Shutdown-Related Data Delays, Fed Speakers, Amazon Prime Days
Investors may not have as much to watch for this week as they expected if the federal government…
At 95, Buffett is still sharpest dealmaker with $10 billion OxyChem deal
Warren Buffett’s shrewd dealmaking instincts remain intact even as the 95-year-old legendary investor inches close to the end…
Older Cancer Clinical Trials May Continue to Offer Relevant Lessons Learned
It is understandable that those responsible for paying the bills associated with the increasingly staggering costs of antineoplastic…